牛SREBP1基因shRNA序列的筛选及其腺病毒载体的构建与鉴定

doi:10.3864/j.issn.0578-1752.2013.23.020

摘要/Abstract

摘要： 【目的】筛选可靶向干扰牛的SREBP1基因的有效shRNA，构建相应腺病毒载体并包装重组腺病毒，为在细胞水平上研究SREBP1基因的功能和作用机制提供基础。【方法】以秦川牛SREBP1基因为研究对象，首先靶向其编码区（coding sequence，CDS）序列设计并合成6条干扰和1条阴性对照shRNA，并构建表达载体pENTR-U6-shRNA。然后与载体psiCHECK-Ⅱ-SREBP1共转染293A细胞，筛选有效的pENTR-U6-shRNA。其次将筛选的pENTR-U6-shRNA和阴性对照pENTR-U6-NC分别与腺病毒骨架载体pAd/PL-DEST体外重组，得到腺病毒重组载体，并在293A细胞包装扩繁得到高滴度腺病毒，GFP标记法测定病毒滴度。最后将病毒侵染牛前体脂肪细胞，实时荧光定量法（qRT-PCR）检测干扰效率。【结果】筛选出靶向牛SREBP1基因干扰效率为87.4%的shRNA-1053。构建了pAd-1053和阴性对照pAd-NC重组腺病毒载体并包装得到Ad-1053和Ad-NC高滴度病毒，测定得到的病毒滴度分别为7×108 GFU•mL-1和9×108 GFU•mL-1。Ad-1053和Ad-NC分别侵染牛前体脂肪细胞，qRT-PCR检测结果显示Ad-1053可显著降低SREBP1基因的mRNA 水平（干扰率＞85%），而Ad-NC对SREBP1基因表达无明显影响。【结论】成功筛选得到靶向干扰牛SREBP1基因的有效shRNA，并包装扩繁获得相应的高滴度重组病毒。

关键词: 牛 , SREBP1 , shRNA , 重组腺病毒

Abstract: 【Objective】 The aim of this study was to construct recombinant adenovirus carrying effective small hairpin RNA (shRNA) which can exclusively interfere NotI bovine sterol-regulatory-element-binding protein 1 (SREBP1) gene expression, thus providing a basis for studying the function and mechanism of SREBP1 gene at cellular level.【Method】According to the coding sequence (CDS) region of SREBP1 gene, six pairs of inhibition shRNA and one pairs of negative control shRNA were designed and further inserted into pENTR-U6 to construct pENTR-U6-shRNA expression vector. The cotransfection of expression vector psiCHECK-Ⅱcarrying SREBP1 and the obtained pENTR-U6-shRNA was carried out in 293 A cell lines to select efficient shRNA. The efficient shRNA and shRNA-NC were connected to pAD/BL-DEST to construct the recombinant plasmid, respectively. The obtained recombinant adenovirus vectors were transfected into 293A cells to package. Then, the adenovirus were amplified and harvested. Real-time PCR (qRT-PCR) was used to detect and confirm the interference effect of the harvested adenovirus on the target gene SREBP1 in bovine pre-adipocytes. The viral titer was determined by GFP labeling method. 【Result】Results showed that shRNA-1053 significantly decreased the expression of SREBP1 by 87.4%. The linearized recombinant adenovirus vector carrying shRNA-1053 and shRNA-NC transfected 293A cells, and further packaged and amplified high-titer recombinant adenovirus Ad-1053 and Ad-NC (7×108 GFU/mL and 9×108 GFU/mL). qRT-PCR results elucidated Ad-1053 significantly down-regulated mRNA expression level of SREBP1 gene in bovine pre-adipocytes (Interfering efficiency ＞85%), while Ad-NC did not.【Conclusion】In this study, the recombinant adenovirus, carrying efficient shRNA designed for RNA interference study of bovine SREBP1 gene, was constructed successfully.

Key words: cattle , SREBP1 , shRNA , recombinant adenovirus

付常振1, 昝林森12, 王虹1, 成功12, 王洪宝12, 李耀坤1, 姜碧杰1, 高建斌1, 杨宁1. 牛SREBP1基因shRNA序列的筛选及其腺病毒载体的构建与鉴定[J]. 中国农业科学, 2013, 46(23): 5026-5036.

FU Chang-Zhen-1, ZAN Lin-Sen-12, WANG Hong-1, CHENG Gong-12, WANG Hong-Bao-12, LI Yao-Kun-1, JIANG Bi-Jie-1, GAO Jian-Bin-1, YANG Ning-1. Selection of Effective SREBP1 shRNA in Cattle and the Construction of Recombinant Adenovirus Vector[J]. Scientia Agricultura Sinica, 2013, 46(23): 5026-5036.

0
/ / 推荐

导出引用管理器 EndNote|Reference Manager|ProCite|BibTeX|RefWorks

链接本文: https://www.chinaagrisci.com/CN/10.3864/j.issn.0578-1752.2013.23.020

https://www.chinaagrisci.com/CN/Y2013/V46/I23/5026

参考文献

[1]Kazala E C, Lozeman F J, Mir P S, Laroche A, Bailey D R, Weselake R J. Relationship of fatty acid composition to intramuscular fat content in beef from crossbred Wagyu cattle. Journal of Animal Science, 1999, 77(7): 1717-1725.

[2]Eberle D, Hegarty B, Bossard P, Ferre P, Foufelle F. SREBP transcription factors: master regulators of lipid homeostasis. Biochimie, 2004, 86(11): 839-848.

[3]Raychaudhuri S, Young B P, Espenshade P J, Loewen C J. Regulation of lipid metabolism: a tale of two yeasts. Current Opinion in Cell Biology, 2012, 24(4): 502-508.

[4]Shimomura I, Shimano H, Horton J D, Goldstein J L, Brown M S. Differential expression of exons 1a and 1c in mRNAs for sterol regulatory element binding protein-1 in human and mouse organs and cultured cells. Journal of Clinical Investigation, 1997, 99(5): 838-845.

[5]Jeon T I, Osborne T F. SREBPs: metabolic integrators in physiology and metabolism. Trends in Endocrinology and Metabolism, 2012, 23(2): 65-72.

[6]廖俊蕾, 赵蕾, 陈曜, 李青, 陈昱杨, 阮堆中, 陈压西. 沉默胆固醇调节原件结合蛋白2基因对炎症因子所致HepG2细胞内胆固醇异常积聚的影响. 中华肝脏病杂志, 2012, 20(7): 526-531.

Liao J L, Zhao L, Chen Y, Li Q, Chen Y Y, Ruan X Z, Chen Y X. Effect of RNAi-mediated silencing of SREBP2 gene on inflammatory cytokine-induced cholesterol accumulation in HepG2 cells. Chinese Journal of Hepatology, 2012, 20(7): 526-531. (in Chinese)

[7]Horton J D, Goldstein J L, Brown M S. SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver. Journal of Clinical Investigation, 2002, 109(9): 1125-1131.

[8]Horton J D, Shimomura I, Brown M S, Hammer R E, Goldstein J L, Shimano H. Activation of cholesterol synthesis in preference to fatty acid synthesis in liver and adipose tissue of transgenic mice overproducing sterol regulatory element-binding protein-2. Journal of Clinical Investigation, 1998, 101(11): 2331-2339.

[9]Shimano H, Horton J D, Shimomura I, Hammer R E, Brown M S, Goldstein J L. Isoform 1c of sterol regulatory element binding protein is less active than isoform 1a in livers of transgenic mice and in cultured cells. Journal of Clinical Investigation, 1997, 99(5): 846-854.

[10]Hasegawa S, Noda K, Maeda A, Matsuoka M, Yamasaki M, Fukui T. Acetoacetyl-CoA synthetase, a ketone body-utilizing enzyme, is controlled by SREBP-2 and affects serum cholesterol levels. Molecular Genetics and Metabolism, 2012, 107(3):553-560.

[11]Hoashi S, Ashida N, Ohsaki H, Utsugi T, Sasazaki S, Taniguchi M, Oyama K, Mukai F, Mannen H. Genotype of bovine sterol regulatory element binding protein-1 (SREBP-1) is associated with fatty acid composition in Japanese Black cattle. Mammalian Genome, 2007, 18(12): 880-886.

[12]Shimano H. Sterol regulatory element-binding proteins (SREBPs): transcriptional regulators of lipid synthetic genes. Progress in Lipid Research, 2001, 40(6): 439-452.

[13]Kim J B, Wright H M, Wright M, Spiegelman B M. ADD1/SREBP1 activates PPARgamma through the production of endogenous ligand. Proceedings of the National Academy of Sciences of the United States of America, 1998, 95(8): 4333-4337.

[14]Kim J B, Spiegelman B M. ADD1/SREBP1 promotes adipocyte differentiation and gene expression linked to fatty acid metabolism. Genes & Development, 1996, 10(9): 1096-1107.

[15]Ma L, Corl B A. Transcriptional regulation of lipid synthesis in bovine mammary epithelial cells by sterol regulatory element binding protein-1. Journal of Dairy Science, 2012, 95(7): 3743-3755.

[16]Liang G, Yang J, Horton J D, Hammer R E, Goldstein J L, Brown M S. Diminished hepatic response to fasting/refeeding and liver X receptor agonists in mice with selective deficiency of sterol regulatory element-binding protein-1c. Journal of Biological Chemistry (JBC), 2002, 277(11): 9520-9528.

[17]Huang Y Z, He H, Sun J J, Wang J, Li Z J, Lan X Y, Lei C Z, Zhang C L, Zhang E P, Wang J Q, Chen H. Haplotype combination of SREBP-1c gene sequence variants is associated with growth traits in cattle. Genome, 2011, 54(6): 507-516.

[18]Huang W C, Li X, Liu J, Lin J, Chung L W. Activation of androgen receptor, lipogenesis, and oxidative stress converged by SREBP-1 is responsible for regulating growth and progression of prostate cancer cells. Molecular Cancer Research, 2012, 10(1): 133-142.

[19]Chu X, Liu L, Na L, Lu H, Li S, Li Y, Sun C. Sterol regulatory element-binding protein-1c mediates increase of postprandial stearic acid, potential target for improving insulin resistance, in hyperlipidemia. Diabetes, 2012, 62(2):561-71.

[20]江萃英, 曾维琼, 陈压西, 戴福宏, 姜平. 乙型肝炎病毒对肝脂肪变患者肝细胞固醇调节元件结合蛋白表达的影响. 中华肝脏病杂志, 2011, 19(8): 608-613.

Jiang C Y, Zeng W Q, Chen Y X, Dai F H, Jiang P. Effect of HBV on the expression of SREBP in the hepatocyte of chronic hepatitis B patients combined with hepatic fatty change. Chinese Journal of Hepatology, 2011, 19(8): 608-613. (in Chinese)

[21]Muller-wieland D, Knebel B, Haas J, Kotzka J. SREBP-1 and fatty liver. Clinical relevance for diabetes, obesity, dyslipidemia and atherosclerosis. Herz, 2012, 37(3): 273-278.

[22]Soufi M, Ruppert V, Kurt B, Schaefer J R. The impact of severe LDL receptor mutations on SREBP-pathway regulation in homozygous familial hypercholesterolemia (FH). Gene, 2012, 499(1): 218-222.

[23]Taghibiglou C, Lu J, Mackenzie I R, Wang Y T, Cashman N R. Sterol regulatory element binding protein-1 (SREBP1) activation in motor neurons in excitotoxicity and amyotrophic lateral sclerosis (ALS): Indip, a potential therapeutic peptide. Biochemical and Biophysical Research Communications, 2011, 413(2): 159-163.

[24]Vitto M F, Luz G, Luciano T F, Marques S O, Souza D R, Pinho R A, Lira F S, Cintra D E, Desouza C T. Reversion of steatosis by SREBP-1c antisense oligonucleotide did not improve hepatic insulin action in diet-induced obesity mice. Hormone and Metabolic Research, 2012, 44(12):885-890.

[25]Zhang C, Chen X, Zhu R M, Zhang Y, Yu T, Wang H, Zhao H, Zhao M, Ji Y L, Chen Y H, Meng X H, Wei W, Xu D X. Endoplasmic reticulum stress is involved in hepatic SREBP-1c activation and lipid accumulation in fructose-fed mice. Toxicology Letters, 2012, 212(3): 229-240.

[26]Jung S Y, Jeon H K, Choi J S, Kim Y J. Reduced expression of FASN through SREBP-1 down-regulation is responsible for hypoxic cell death in HepG2 cells. Journal of Cellular Biochemistry, 2012, 113(12):3730-9.

[27]Elbashir S M, Harborth J, Weber K, Tuschl T. Analysis of gene function in somatic mammalian cells using small interfering RNAs. Methods, 2002, 26(2): 199-213.

[28]Holen T, Amarzguioui M, Wiiger M T, Babaie E, Prydz H. Positional effects of short interfering RNAs targeting the human coagulation trigger tissue factor. Nucleic Acids Research, 2002, 30(8): 1757-1766.

[29]Lee N S, Dohjima T, Bauer G, Li H, Li M J, Ehsani A, Salvaterra P, Rossi J. Expression of small interfering RNAs targeted against HIV-1 rev transcripts in human cells. Nature Biotechnology, 2002, 20(5): 500-505.

[30]Yu J Y, Deruiter S L, Turner D L. RNA interference by expression of short-interfering RNAs and hairpin RNAs in mammalian cells. Proceedings of the National Academy of Sciences of the United States of America, 2002, 99(9): 6047-6052.

[31]Kapadia S B, Brideau-andersen A, Chisari F V. Interference of hepatitis C virus RNA replication by short interfering RNAs. Proceedings of the National Academy of Sciences of the United States of America, 2003, 100(4): 2014-2018.

[32]Mcmanus M T, Petersen C P, Haines B B, Chen J, Sharp P A. Gene silencing using micro-RNA designed hairpins. RNA-a Publication of the RNA Society, 2002, 8(6): 842-850.

[33]邓清华, 付世新, 刘国文, 刘磊, 王建国, 白鸽, 朱晓岩, 李慧萍, 李小兵, 王哲. siRNA特异性抑制犊牛原代肝细胞SREBP-1c基因的表达. 中国兽医学报, 2011(7): 1050-1053.

Deng H Q, Fu S X, Liu G W, Liu L, Wang J G, Bai G, Zhu X Y, Li H P, Li X B, Wang Z. Specific inhibition effect of siRNA on SREBP-1c gene expression in calf primary hepatocyte. Chinese Journal of Veterinary Science, 2011(7): 1050-1053. (in Chinese)

[34]Tuschl T. Selection of siRNA sequences for mammalian RNAi. Cold Spring Harbor Protocols, 2006, doi: 10. 1101/pdb.prot4339.

[35]Dallas A, Johnston B H. Design and Chemical Modification of Synthetic Short shRNAs as Potent RNAi Triggers. Methods in Molecular Biology, 2013, 942: 279-290.

[36]Lybarger L, Dempsey D, FT K J, Chervenak R. Rapid generation and flow cytometric analysis of stable GFP-expressing cells. Cytometry, 1996, 25(3): 211-220.

[37]Hitt D C, Booth J L, Dandapani V, Pennington L R, Gimble J M, Metcalf J. A flow cytometric protocol for titering recombinant adenoviral vectors containing the green fluorescent protein. Molecular Biotechnology, 2000, 14(3): 197-203.

[38]Ge Q, Ilves H, Dallas A, Kumar P, Shorenstein J, Kazakov S A, Johnston B H. Minimal-length short hairpin RNAs: the relationship of structure and RNAi activity. RNA-a Publication of the RNA Society, 2010, 16(1): 106-117.

[39]Vlassov A V, Korba B, Farrar K, Mukerjee S, Seyhan A A, Ilves H, Kaspar R L, Leake D, Kazakov S A, Johnston B H. shRNAs targeting hepatitis C: effects of sequence and structural features, and comparision with siRNA. Oligonucleotides, 2007, 17(2): 223-236.

[40]Breyer B, Jiang W, Cheng H, Zhou L, Paul R, Feng T, He T C. Adenoviral vector-mediated gene transfer for human gene therapy. Current Gene Therapy, 2001, 1(2): 149-162.

[41]Mcconnell M J, Imperiale M J. Biology of adenovirus and its use as a vector for gene therapy. Human Gene Therapy, 2004, 15(11): 1022-1033.

[42]王伟, 罗军, 赵旺生, 李建华, 张晓, 王龙坛. 西农萨能羊FAS基因shRNA序列筛选及其腺病毒载体的构建. 西北农业学报, 2010(3): 6-12.

Wang W, Luo J, Zhao W S, Li J H, Zhang X, Wang L T. Screening of shRNA sequence target Xinong Saanen goat FAS gene and the construction of recombinant adenovirus vector. Acta Agriculturae Boreali-Occidentalis Sinica, 2010(3): 6-12. (in Chinese)

[43]钟瑜, 罗军, 王维, 胡仕良, 李君, 孙雨婷, 郝娟, 石恒波. 奶山羊LXRα基因shRNA序列的筛选及腺病毒载体的构建与鉴定. 西北农林科技大学学报: 自然科学版, 2011(11): 41-47.

Zhong Y, Luo J, Wang W, Hu S L, Li J, Sun Y T, Hao J,Shi H B. Screening of shRNA sequence and construction and identification of recombinant adenovirus vector of LXRα gene of dairy goats. Journal of Northwest A&F University: Natural Science Edition, 2011(11): 41-47. (in Chinese)